概括
胰岛素诱导的轻度低血糖会损害糖尿病患者的症状识别和上腺素反应,增加严重低血糖的风险. 这种效应即使没有自主神经病变也存在.
科学领域:
- 内分泌学 在内分泌学.
- 代谢障碍 代谢障碍 代谢障碍
- 神经科学是一个神经科学.
背景情况:
- 胰岛素诱导的低血糖是糖尿病管理中的常见并发症.
- 低血糖症的意识受损是一个重大的临床挑战.
研究的目的:
- 评估轻度低血糖症对症状,生理变化和上腺素反应的影响.
- 为了比较健康个体和胰岛素依赖糖尿病患者的反应,包括那些意识受损的人.
主要方法:
- 在10名正常患者和15名糖尿病患者中诱导轻度低血糖 (3.2 mmol/l和2.5 mmol/l).
- 监测血糖,反应时间,症状,生理参数和血上腺素水平.
- 对低血糖症状意识的评估.
主要成果:
- 在3.2 mmol/l时,在正常人和一些糖尿病患者中观察到延长反应时间和增加的血上腺素.
- 在2.5mmol/l的水平下,只有4/15的糖尿病患者识别了低血糖症,而9/10的正常人则没有.
- 显著的生理反应 (症状,出汗,血压变化) 主要发生在正常和有意识的糖尿病患者中.
- 在正常和有意识的糖尿病患者中,上腺素反应明显,而在所有组中,反应时间仍然延长.
结论:
- 上腺素反应和症状识别障碍在糖尿病患者中很常见,即使没有诊断的自主神经病变或主观无意识.
- 无法识别血糖水平下降可能会增加糖尿病患者严重低血糖的风险.
- 这些发现强调了在糖尿病护理中需要仔细监测葡萄糖和管理策略的需要.
相关概念视频
01:25The Sympathetic Nervous System
Overview
01:16Sympathetic Activation
The sympathetic division can influence tissues and organs by releasing norepinephrine at peripheral synapses and distributing epinephrine and norepinephrine through the bloodstream. In times of crisis or stress, sympathetic activation occurs, which is regulated by sympathetic centers in the hypothalamus. As a result, sympathetic activation prepares the body for physical exertion, rapid ATP production, and heightened alertness, allowing individuals to respond effectively to challenging or...
01:18Disorders of the Autonomic Nervous System
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Raynaud's disease, also known as Raynaud's phenomenon, is a...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...